ACLX (STOCKS)
Arcellx, Inc. Common Stock
$69.880000
+2.640000 (+3.93%)
Prev close: $67.240000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Rami Elghandour
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4,041.24M
- Employees
- 163
- P/E (TTM)
- -17.83
- P/B (TTM)
- 8.81
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
9
Strong Buy
14
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-0.99 | $-1.08 | +0.0912 | +8.44% |
|
Jun 2025 (Q2)
|
$-0.94 | $-1.04 | +0.0978 | +9.42% |
|
Mar 2025 (Q1)
|
$-1.13 | $-0.77 | -0.3574 | -46.26% |
|
Dec 2024 (Q4)
|
$-0.87 | $-0.57 | -0.2972 | -51.89% |
Financial Statements
| Assets | $655.92M |
| Current Assets | $472.08M |
| Noncurrent Assets | $183.84M |
| Fixed Assets | $43.08M |
| Other Non-current Assets | $140.76M |
| Liabilities | $215.14M |
| Current Liabilities | $118.39M |
| Accounts Payable | $4.20M |
| Other Current Liabilities | $114.19M |
| Noncurrent Liabilities | $96.75M |
| Equity | $440.78M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $440.78M |
| Liabilities And Equity | $655.92M |